Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials

Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials

Moeber M Mahzari,1– 3,* Muhannad Qirnas Alqirnas,1,2,4,* Moustafa S Alhamadh,1– 3 Faisal Alrasheed,1,2 Abdulrahman Yousef Alhabeeb,1,2 Wedad Al Madani,5 Hussain Aldera1,2 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 2King Abdulla...

Celý popis

Podrobná bibliografie
Hlavní autoři: Mahzari MM, Alqirnas MQ, Alhamadh MS, Alrasheed F, Alhabeeb AY, Al Madani W, Aldera H
Médium: Článek
Jazyk:English
Vydáno: Dove Medical Press 2024-03-01
Edice:Diabetes, Metabolic Syndrome and Obesity
Témata:
diabetes
dipeptidyl peptidase iv
efficacy
safety
chronic kidney disease
On-line přístup:https://www.dovepress.com/efficacy-and-safety-of-the-utilization-of-dipeptidyl-peptidase-iv-inhi-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/efficacy-and-safety-of-the-utilization-of-dipeptidyl-peptidase-iv-inhi-peer-reviewed-fulltext-article-DMSO

Podobné jednotky